P2.13-09 Efficacy and Safety of Osimertinib After Prior EGFR TKI: Analysis of Patients Underrepresented in Randomized Clinical Trials
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1404
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV